Login / Signup

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Robbert BoudewijnsHendrik-Jan ThibautSuzanne J F KapteinRong LiValentijn VergoteLaura SeldeslachtsJohan Van WeyenberghCarolien De KeyzerLindsey BervoetsSapna SharmaLaurens LiesenborghsJi MaSander JansenDominique Van LooverenThomas VercruysseXinyu WangDirk JochmansErik MartensKenny RooseDorien De VliegerBert SchepensTina Van BuytenSofie JacobsYanan LiuJoan Martí-CarrerasBert VanmechelenTony Wawina-BokalangaLeen DelangJoana Rocha-PereiraLotte CoelmontWinston ChiuPieter LeyssenElisabeth HeylenDominique ScholsLanjiao WangLila CloseJelle MatthijnssensMarc Van RanstVeerle CompernolleGeorg SchrammKoen Van LaereXavier SaelensNico CallewaertGhislain OpdenakkerPiet MaesBirgit WeynandChristopher J CawthorneGreetje Vande VeldeZhongde WangJohan NeytsKai Dallmeier
Published in: Nature communications (2020)
Emergence of SARS-CoV-2 causing COVID-19 has resulted in hundreds of thousands of deaths. In search for key targets of effective therapeutics, robust animal models mimicking COVID-19 in humans are urgently needed. Here, we show that Syrian hamsters, in contrast to mice, are highly permissive to SARS-CoV-2 and develop bronchopneumonia and strong inflammatory responses in the lungs with neutrophil infiltration and edema, further confirmed as consolidations visualized by micro-CT alike in clinical practice. Moreover, we identify an exuberant innate immune response as key player in pathogenesis, in which STAT2 signaling plays a dual role, driving severe lung injury on the one hand, yet restricting systemic virus dissemination on the other. Our results reveal the importance of STAT2-dependent interferon responses in the pathogenesis and virus control during SARS-CoV-2 infection and may help rationalizing new strategies for the treatment of COVID-19 patients.
Keyphrases